These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7648764)

  • 21. [Inhibitory action of E3810 on H+,K(+)-ATPase and gastric acid secretion in vitro].
    Fujisaki H; Oketani K; Shibata H; Murakami M; Fujimoto M; Wakabayashi T; Yamatsu I; Takeguchi N
    Nihon Yakurigaku Zasshi; 1993 Dec; 102(6):389-97. PubMed ID: 8282270
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The hydroxylation of omeprazole correlates with S-mephenytoin and proguanil metabolism.
    Kortunay S; Basci NE; Bozkurt A; Isimer A; Sayal A; Kayaalp SO
    Eur J Clin Pharmacol; 1997; 53(3-4):261-4. PubMed ID: 9476042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A proton pump inhibitor, E3810, has antibacterial activity through binding to Helicobacter pylori.
    Hirai M; Azuma T; Ito S; Kato T; Kohli Y
    J Gastroenterol; 1995 Aug; 30(4):461-4. PubMed ID: 7550855
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Specific proton pump inhibitors E3810 and lansoprazole affect the recovery process of gastric secretion in rats differently.
    Tomiyama Y; Morii M; Takeguchi N
    Biochem Pharmacol; 1994 Nov; 48(11):2049-55. PubMed ID: 7802694
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of genetically determined S-mephenytoin 4-hydroxylation status and cigarette smoking on the single-dose pharmacokinetics of oral alprazolam.
    Otani K; Yasui N; Kaneko S; Ohkubo T; Osanai T; Sugawara K; Hayashi K; Chiba K; Ishizaki T
    Neuropsychopharmacology; 1997 Jan; 16(1):8-14. PubMed ID: 8981384
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolic disposition of imipramine in oriental subjects: relation to metoprolol alpha-hydroxylation and S-mephenytoin 4'-hydroxylation phenotypes.
    Koyama E; Sohn DR; Shin SG; Chiba K; Shin JG; Kim YH; Echizen H; Ishizaki T
    J Pharmacol Exp Ther; 1994 Nov; 271(2):860-7. PubMed ID: 7965806
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Different biochemical modes of action of two irreversible H+,K(+)-ATPase inhibitors, omeprazole and E3810.
    Morii M; Takeguchi N
    J Biol Chem; 1993 Oct; 268(29):21553-9. PubMed ID: 8408006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polymorphic hydroxylation of S-mephenytoin and omeprazole metabolism in Caucasian and Chinese subjects.
    Andersson T; Regårdh CG; Lou YC; Zhang Y; Dahl ML; Bertilsson L
    Pharmacogenetics; 1992 Feb; 2(1):25-31. PubMed ID: 1302040
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidence of S-mephenytoin hydroxylation deficiency in a Korean population and the interphenotypic differences in diazepam pharmacokinetics.
    Sohn DR; Kusaka M; Ishizaki T; Shin SG; Jang IJ; Shin JG; Chiba K
    Clin Pharmacol Ther; 1992 Aug; 52(2):160-9. PubMed ID: 1505151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diazepam metabolism in native Chinese poor and extensive hydroxylators of S-mephenytoin: interethnic differences in comparison with white subjects.
    Zhang YA; Reviriego J; Lou YQ; Sjöqvist F; Bertilsson L
    Clin Pharmacol Ther; 1990 Nov; 48(5):496-502. PubMed ID: 2225709
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ethnic and genetic determinants of omeprazole disposition and effect.
    Caraco Y; Lagerstrom PO; Wood AJ
    Clin Pharmacol Ther; 1996 Aug; 60(2):157-67. PubMed ID: 8823233
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Accelerated caffeine metabolism after omeprazole treatment is indicated by urinary metabolite ratios: coincidence with plasma clearance and breath test.
    Rost KL; Roots I
    Clin Pharmacol Ther; 1994 Apr; 55(4):402-11. PubMed ID: 8162667
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modeled Hepatic/Plasma Exposures of Omeprazole Prescribed Alone in Cytochrome P450 2C19 Poor Metabolizers Are Likely Associated with Hepatic Toxicity Reported in a Japanese Adverse Event Database.
    Adachi K; Ohyama K; Tanaka Y; Murayama N; Shimizu M; Saito Y; Yamazaki H
    Biol Pharm Bull; 2024; 47(5):1028-1032. PubMed ID: 38797695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The mephenytoin oxidation polymorphism is partially responsible for the N-demethylation of imipramine.
    Skjelbo E; Brøsen K; Hallas J; Gram LF
    Clin Pharmacol Ther; 1991 Jan; 49(1):18-23. PubMed ID: 1988236
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bioavailability and plasma concentration of omeprazole in healthy bangladeshi population after ingestion.
    Ghosh CK; Ishaque SM; Mahmuduzzaman M; Bachar SC; Hasan M; Uddoula MS
    Mymensingh Med J; 2013 Oct; 22(4):773-80. PubMed ID: 24292311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The proton pump inhibitor, E3810, binds to the N-terminal half of the alpha-subunit of gastric H+,K(+)-ATPase.
    Morii M; Hamatani K; Takeguchi N
    Biochem Pharmacol; 1995 Jun; 49(12):1729-34. PubMed ID: 7598734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Slow omeprazole metabolizers are also poor S-mephenytoin hydroxylators.
    Andersson T; Regårdh CG; Dahl-Puustinen ML; Bertilsson L
    Ther Drug Monit; 1990 Jul; 12(4):415-6. PubMed ID: 2396316
    [No Abstract]   [Full Text] [Related]  

  • 38. Pharmacokinetics of citalopram in relation to the sparteine and the mephenytoin oxidation polymorphisms.
    Sindrup SH; Brøsen K; Hansen MG; Aaes-Jørgensen T; Overø KF; Gram LF
    Ther Drug Monit; 1993 Feb; 15(1):11-7. PubMed ID: 8451774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proguanil metabolism in relation to S-mephenytoin oxidation in a Turkish population.
    Basci NE; Bozkurt A; Kortunay S; Isimer A; Sayal A; Kayaalp SO
    Br J Clin Pharmacol; 1996 Dec; 42(6):771-3. PubMed ID: 8971434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Omeprazole preferentially inhibits the metabolism of (+)-(S)-citalopram in healthy volunteers.
    Rocha A; Coelho EB; Sampaio SA; Lanchote VL
    Br J Clin Pharmacol; 2010 Jul; 70(1):43-51. PubMed ID: 20642546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.